# FUSIONPHARM, INC. — Form D

FUSIONPHARM, INC. of DENVER, X1, a company, filed a Form D exempt-offering notice with the SEC on 2012-06-20. The offering totals $1.0M, of which $149K was reported sold. Industry: Agriculture.

## Offering

- Filed: 2012-06-20
- Form: D
- Accession: 0001552474-12-000002
- Industry: Agriculture
- Exemptions: 04.1
- Total offering: $1.0M
- Amount sold: $149K
- Remaining: $851K
- Minimum investment: $25K
- Investors: 10
- Date of first sale: 2011-03-01
- Security types: equity
- Revenue range: $1 - $1,000,000
- SEC file number: 021-180015

## Issuer

- Name: FUSIONPHARM, INC.
- CIK: 0001552474
- Entity type: Corporation
- Jurisdiction: NEVADA
- Address: 1610 WYNKOOP STREET, DENVER, X1, 80202
- Phone: 7204580686

## Officers, directors & promoters (2)

| Name | Role | Location |
| --- | --- | --- |
| DITTMAN M SCOTT | Director | DENVER, CO |
| DITTMAN M SCOTT | Executive Officer | DENVER, CO |

## More

- [CIK 1552474 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1552474&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001552474-12-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.